Related Experiment Video

Updated: Sep 30, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure

Siva B Mohan1, Miriam Parker, Mohammad Wehbi

  • 1Department of Internal Medicine, Atlanta Medical Center, GA 30312, USA.

Cleveland Clinic Journal of Medicine
|June 14, 2002
PubMed

Insights

Idiopathic dilated cardiomyopathy (IDCM) origins remain unclear, posing challenges for clinicians in diagnosis and treatment. This review covers IDCM classifications, diagnostics, and therapeutic strategies to improve patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Idiopathic dilated cardiomyopathy (IDCM) presents significant clinical challenges.
  • Elucidating the precise origins of IDCM is an ongoing research priority.

Purpose of the Study:

  • To review current classification schemes for dilated cardiomyopathy.
  • To outline contemporary diagnostic and therapeutic options for IDCM.
  • To discuss treatment goals aimed at improving patient survival and symptoms.

Main Methods:

  • Literature review of classification systems for dilated cardiomyopathy.
  • Synthesis of current diagnostic modalities for IDCM.
  • Analysis of established and emerging therapeutic strategies for IDCM.

Main Results:

  • Multiple classification schemes exist for dilated cardiomyopathy, aiding in categorization.
  • Diagnostic approaches encompass clinical evaluation, imaging, and genetic testing.
  • Therapeutic options range from medical management to advanced interventions, with varying goals.

Conclusions:

  • Despite advances, IDCM diagnosis and treatment remain complex.
  • A comprehensive understanding of classification, diagnostics, and therapeutics is crucial for effective patient management.
  • Continued research into IDCM origins is vital for developing targeted therapies.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...